Britons expect continued collaboration in (bio)pharmaceutical research
Survey finds British adults expect pharma to continue to work together to advance both COVID-19 treatments and innovations for other diseases.
List view / Grid view
Survey finds British adults expect pharma to continue to work together to advance both COVID-19 treatments and innovations for other diseases.
Research has revealed that the biotechnology industry was worth £1.3 billion in 2019, marking its third-highest year for investment.
MIT researchers have developed an algorithm which uses a new technique to predict missing data from clinical trial information.